Impact of the Extent of Weight Loss before Administration on the Efficacy of Anamorelin in Advanced Pancreatic Cancer Patients with Cachexia-Reference-Cited by-同舟云学术

Impact of the Extent of Weight Loss before Administration on the Efficacy of Anamorelin in Advanced Pancreatic Cancer Patients with Cachexia

Published:2023 Issue: Volume: Page:
ISSN:0918-2918
Container-title:Internal Medicine
language:en
Short-container-title:Intern. Med.

Author:

Takeda Tsuyoshi¹,Sasaki Takashi¹,Okamoto Takeshi¹,Ishitsuka Takahiro¹,Yamada Manabu¹,Nakagawa Hiroki¹,Mie Takafumi¹,Furukawa Takaaki¹,Kasuga Akiyoshi¹,Matsuyama Masato¹,Ozaka Masato¹,Sasahira Naoki¹

Affiliation:

1. Department of Hepato-Biliary-Pancreatic Medicine, Cancer Institute Hospital of Japanese Foundation for Cancer Research, Japan

Publisher

Japanese Society of Internal Medicine

Subject

General Medicine,Internal Medicine

Link

https://www.jstage.jst.go.jp/article/internalmedicine/advpub/0/advpub_0730-22/_pdf

Reference23 articles.

1. 1. Fearon K, Strasser F, Anker SD, et al. Definition and classification of cancer cachexia: an international consensus. The Lancet Oncology 12 (5): 489-495, 2011.

2. 2. Martin L, Birdsell L, Macdonald N, et al. Cancer cachexia in the age of obesity: skeletal muscle depletion is a powerful prognostic factor, independent of body mass index. J Clin Oncol 31 (12): 1539-1547, 2013.

3. 3. da Rocha IMG, Marcadenti A, de Medeiros GOC, et al. Is cachexia associated with chemotherapy toxicities in gastrointestinal cancer patients? A prospective study. Journal of cachexia, sarcopenia and muscle 10 (2): 445-454, 2019.

4. 4. Takeda T, Sasaki T, Suzumori C, et al. The impact of cachexia and sarcopenia in elderly pancreatic cancer patients receiving palliative chemotherapy. Int J Clin Oncol 2021.

5. 5. Ozola Zalite I, Zykus R, Francisco Gonzalez M, et al. Influence of cachexia and sarcopenia on survival in pancreatic ductal adenocarcinoma: a systematic review. Pancreatology: official journal of the International Association of Pancreatology (IAP) [et al] 15 (1): 19-24, 2015.

Cited by 13 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Real-world data of anamorelin in advanced gastrointestinal cancer patients with cancer cachexia;BMC Palliative Care;2024-08-24

2. CONUT score as a predictor for anamorelin efficacy in patients with cancer cachexia receiving chemotherapy;Journal of Pharmaceutical Health Care and Sciences;2024-07-10

3. Anamorelin for the Treatment of Cancer Anorexia-Cachexia Syndrome;Current Oncology Reports;2024-05-21

4. The efficacy and safety of anamorelin among patients with diabetes;International Journal of Clinical Oncology;2024-05-09

5. Real‐world safety and effectiveness of anamorelin for cancer cachexia: Interim analysis of post‐marketing surveillance in Japan;Cancer Medicine;2024-05